Claude Boucheix

Title: Claude Boucheix: Innovator in Cancer Management

Introduction

Claude Boucheix is a notable inventor based in Villejuif, France. He has made significant contributions to the field of cancer management, particularly through his innovative approaches targeting the Co-029 protein. With a total of 3 patents to his name, Boucheix's work is pivotal in advancing cancer treatment methodologies.

Latest Patents

Boucheix's latest patents focus on methods for cancer management targeting Co-029. The disclosures relate to a Co-029 inhibitor designed to inhibit the migration of cancer cells that express Co-029. This innovative approach not only aims to treat cancer but also seeks to prevent cancer metastasis. The patents include pharmaceutical compositions comprising the Co-029 inhibitor and provide Co-029 antibodies. Furthermore, they outline methods for predicting a patient's response to treatment with a Co-029 inhibitor, diagnosing cancer in patients, and predicting survival rates for cancer patients.

Career Highlights

Throughout his career, Claude Boucheix has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and the Université de Paris XI Paris Sud. His research has significantly impacted the understanding and treatment of cancer, showcasing his dedication to improving patient outcomes.

Collaborations

Boucheix has collaborated with notable colleagues, including Eric Rubinstein and Céline Greco. These partnerships have further enriched his research and contributed to the advancements in cancer management.

Conclusion

Claude Boucheix stands out as an influential inventor in the realm of cancer treatment. His innovative patents and collaborations reflect his commitment to enhancing medical practices and improving the lives of cancer patients.